Search clinical trials for: Naltrexone (oral)

Total 8590 results

Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Opioid Use Disorder

United States
Alkermes, Inc.

Completed

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

Alcohol Dependence
Purdue Pharma LP

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

ECG Effects

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Cocaine Use Reduction With Buprenorphine (CURB)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Opioid Dependence

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone for Heavy Drinking in Young Adults

Alcoholism | Alcohol Consumption | Alcoholic Intoxication | Alcohol-induced Disorders

United States
University of Oslo
Norwegian Institute of Public Health; Oslo University Hospital; The Research... and other collaborators

Completed

Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway (NTX-SBX)

Opioid Dependence

Norway
Elite Laboratories, Inc

Completed

A Study to Evaluate Safety and Efficacy Following Dosing of Oxycodone/Naltrexone for Treatment of Adults With Pain Following Bunionectomy Surgery

Pain

United States
Institute of Liver and Biliary Sciences, India

Completed

Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.

Liver Cirrhosis

India
Alkermes, Inc.

Completed

ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals

Opiate Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
Alkermes, Inc.

Completed

ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

Alcohol Dependence

United States
Alkermes, Inc.

Completed

ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence

Alcohol Dependence
Tasly GeneNet Pharmaceuticals Co., Ltd

Recruiting

A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

Charcot-Marie-Tooth Type 1A

China
Milton S. Hershey Medical Center

Terminated

Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis

Endometriosis

United States
Xhale Assurance
National Institute on Drug Abuse (NIDA)

Completed

An Adherence Tool to Manage Narcotic -Addicted HIV Patients

Healthy Adults

United States
University of Pennsylvania

Completed

Understanding Treatment Response With Naltrexone Among White Alcoholics (DEFINE II)

Alcoholism

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone for Early Problem Drinkers

Alcoholism

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder (ADAPT-2)

Methamphetamine Use Disorder

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone for Relapse Prevention

Alcoholism

United States
US Department of Veterans Affairs

Completed

Treating Alcohol Use In Older Adults With Depression

Depression | Alcoholism

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Use of Naltrexone in a Clinical Setting

Alcoholism

United States
Shenzhen Sciencare Medical Industries Co., Ltd.

Recruiting

Exploring the PK of Different Doses of Naltrexone in Patients With AUD

AUD

China
Timothy Smith

Completed

The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations (TEST CANADA)

Opioid Intoxication

Canada
Alza Corporation, DE, USA

Completed

Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers

Biological Availability
National Institute on Alcohol Abuse and Alcoholism...

Completed

Naltrexone, Craving, and Drinking

Alcoholism

United States
VA Office of Research and Development

Completed

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence

Alcoholism

United States
Pfizer

Terminated

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Chronic Pain

United States
State University of New York - Upstate Medical...
US Department of Veterans Affairs

Terminated

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

Alcohol Dependence | Veterans

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Depot Naltrexone Treatment of Opioid Dependent Parolees

Opioid Dependence

United States
Yale University
National Center for Responsible Gaming

Completed

Investigation of Naltrexone for Pathological Gambling

Pathological Gambling

United States
VA Loma Linda Health Care System

Completed

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

Sleep Apnea, Central | Altitude

United States
Yale University
Ethel F. Donaghue Women's Health Investigator Program at Yale

Completed

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Obesity | Schizophrenia | Schizoaffective Disorder

United States
Johns Hopkins University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Treatment for Alcoholism

Alcoholism

United States
Hadassah Medical Organization
Jerusalem Institute for Child Development

Unknown

Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)

Pervasive Developmental Disorder

Israel
State University of New York - Upstate Medical...

Completed

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

Autism Spectrum Disorder

United States
State University of New York - Upstate Medical...
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

Mental Disorders | Alcoholism | Schizophrenia | Alcohol Abuse | Alcohol-related Disorders

United States
University of Pennsylvania

Recruiting

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc)

Giant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Granulomatosis With Polyangiitis | Takayasu Arteritis | Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Churg-Strauss Syndrome (CSS)

United States
Rosemary Claire Roden
Children's Miracle Network

Enrolling by invitation

Oral Naltrexone In Pediatric Eating Disorders (ONPED)

Bulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging Type

United States
Lars Tanum
Oslo University Hospital; Haukeland University Hospital; The Hospital of Vestfold and other collaborators

Completed

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery (NaltRec)

Opioid-use Disorder

Norway
University of Pennsylvania
Patient-Centered Outcomes Research Institute

Completed

Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone (OAPXRNTX)

Opiate Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Medication-Assisted Treatment for Youth With Substance Use Disorders

Opioid Use Disorder | Opioid Dependence

United States
Stanford University

Withdrawn

Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

Fibromyalgia
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Naltrexone Treatment for Alcoholic Women

Alcoholism | Eating Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
Washington University School of Medicine

Completed

Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia | Lichen Planopilaris

United States
University of Oslo

Terminated

Naltrexone Implants as Relapse Prevention

Opioid Dependency
Finnish Institute for Health and Welfare

Completed

Treatment of Pathological Gambling With Naltrexone Pharmacotherapy and Brief Intervention

Pathological Gambling

Finland
State University of New York - Upstate Medical...

Completed

Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) (vivitrol)

Alcohol Dependence | Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Eunice Kennedy Shriver National Institute of Child...

Terminated

Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones

Amenorrhea | Aplastic Anemia | Menorrhagia

United States

Search clinical trials for: Naltrexone (oral)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations